Trial · NCT02014584
Participant flow54
How many started, completed or left each group, period by period.
1 to 20 of 54
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Blind Period (24 Weeks) | STARTED | Placebo | 59 | |
| Double-Blind Period (24 Weeks) | STARTED | Dutasteride 0.5 mg | 58 | |
| Double-Blind Period (24 Weeks) | STARTED | Placebo (DB)/Dutasteride 0.5 mg (OL) | 0 | |
| Double-Blind Period (24 Weeks) | STARTED | Dutasteride 0.5 mg (DB)/Dutasteride 0.5 mg (OL) | 0 | |
| Double-Blind Period (24 Weeks) | STARTED | Targeted F/U: Placebo (DB)/Dutasteride 0.5 mg (OL) | 0 | |
| Double-Blind Period (24 Weeks) | STARTED | Targeted F/U: Dutasteride 0.5 mg (DB)/Dutasteride 0.5 mg (OL) | 0 | |
| Double-Blind Period (24 Weeks) | COMPLETED | Placebo | 57 | |
| Double-Blind Period (24 Weeks) | COMPLETED | Dutasteride 0.5 mg | 52 | |
| Double-Blind Period (24 Weeks) | COMPLETED | Placebo (DB)/Dutasteride 0.5 mg (OL) | 0 | |
| Double-Blind Period (24 Weeks) | COMPLETED | Dutasteride 0.5 mg (DB)/Dutasteride 0.5 mg (OL) | 0 | |
| Double-Blind Period (24 Weeks) | COMPLETED | Targeted F/U: Placebo (DB)/Dutasteride 0.5 mg (OL) | 0 | |
| Double-Blind Period (24 Weeks) | COMPLETED | Targeted F/U: Dutasteride 0.5 mg (DB)/Dutasteride 0.5 mg (OL) | 0 | |
| Double-Blind Period (24 Weeks) | NOT COMPLETED | Placebo | 2 | |
| Double-Blind Period (24 Weeks) | NOT COMPLETED | Dutasteride 0.5 mg | 6 | |
| Double-Blind Period (24 Weeks) | NOT COMPLETED | Placebo (DB)/Dutasteride 0.5 mg (OL) | 0 | |
| Double-Blind Period (24 Weeks) | NOT COMPLETED | Dutasteride 0.5 mg (DB)/Dutasteride 0.5 mg (OL) | 0 | |
| Double-Blind Period (24 Weeks) | NOT COMPLETED | Targeted F/U: Placebo (DB)/Dutasteride 0.5 mg (OL) | 0 | |
| Double-Blind Period (24 Weeks) | NOT COMPLETED | Targeted F/U: Dutasteride 0.5 mg (DB)/Dutasteride 0.5 mg (OL) | 0 | |
| Open-Label Period (24 Weeks) | STARTED | Placebo | 0 | |
| Open-Label Period (24 Weeks) | STARTED | Dutasteride 0.5 mg | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02014584/flow